“Hepatitis b”的搜索结果，显示 311-320 项，共有 9258 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

2. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.

4. 乳腺癌- 医生与科室- 妙佑医疗国际

   B · 查找姓氏以该字母开头的 ... Research Profiles. 编辑搜索过滤条件. close. 缩小搜索范围. 按姓名字母顺序A-Z. 以下医生姓氏开头为A A · 当前文本以下医生姓氏开头为B B ...

5. 乳腺癌- 医生与科室- 妙佑医疗国际

   当前文本以下医生姓氏开头为B B · 以下医生姓氏开头为C C · 以下医生姓氏开头为D D; 没有医生姓氏开头为E E; 以下医生姓氏开头为F F · 以下医生姓氏开头为G G · 以下医生 ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

7. 血液科- 临床试验- 妙佑医疗国际

   Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia. Rochester, Minn. This ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...